Biosig Technologies, Inc. (STEX) SEC Filings — 2024

Filings

• BioSig Technologies Files 8-K on Director/Officer Changes & Shareholder Votes — 8-K · Dec 31, 2024
• BioSig Technologies Files 8-K for Material Definitive Agreement — 8-K · Dec 18, 2024
• BioSig to Acquire PURE BIOSCIENCE for $10.5M — 8-K · Dec 6, 2024
• BioSig Technologies 2024 Annual Meeting Proxy Statement Filed — DEF 14A · Nov 18, 2024
• Biosig Technologies, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• BioSig Technologies Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• BioSig Technologies Files 8-K — 8-K · Nov 13, 2024
• BioSig Technologies to Acquire PediaTrust, LLC — 8-K · Oct 29, 2024
• BioSig Technologies Files 8-K Current Report — 8-K · Oct 22, 2024
• BioSig Technologies Relocates Principal Executive Offices — 8-K · Sep 13, 2024
• BioSig Technologies Reports Q2 2024 Financials — 10-Q · Aug 14, 2024
• BioSig Technologies to Acquire PediaQ for $10M — 8-K · Jul 24, 2024
• BioSig Technologies Files S-1 for Security Offering — S-1 · Jun 27, 2024
• BioSig Technologies Secures $10M Financing — 8-K · Jun 26, 2024
• BioSig Technologies Faces Delisting Notice — 8-K · Jun 11, 2024
• BioSig Technologies Appoints New CFO, Adjusts Officer Compensation — 8-K · Jun 10, 2024
• BioSig Technologies Files 8-K with Key Agreements and Sales — 8-K · May 30, 2024
• BioSig Technologies to Acquire PediaTrust, LLC — 8-K · May 28, 2024
• BioSig Technologies Announces Board Changes — 8-K · May 21, 2024
• BioSig Technologies Files Q1 2024 10-Q — 10-Q · May 20, 2024
• BioSig Technologies Appoints New CMO, Director — 8-K · May 7, 2024
• BioSig Technologies Appoints New Chief Medical Officer — 8-K · May 3, 2024
• BioSig Technologies Appoints New CMO, Director — 8-K · May 2, 2024
• BioSig Technologies, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 16, 2024
• BioSig Technologies Faces Listing Rule Concerns — 8-K · Mar 18, 2024
• BioSig Technologies Enters Material Definitive Agreement — 8-K · Mar 12, 2024
• BioSig Technologies Faces Delisting Concerns — 8-K · Mar 11, 2024
• BioSig Technologies Reports Executive Changes and Compensation Adjustments — 8-K · Feb 28, 2024
• BioSig Technologies Reports Executive Changes and Compensation Adjustments — 8-K · Feb 21, 2024
• Biosig Technologies, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• BioSig Confirms NASDAQ Listing for Common Stock — 8-K · Feb 6, 2024
• BioSig Amends 8-K on Exit Costs, Officer Compensation — 8-K/A · Feb 2, 2024
• BioSig Reports Exit Costs, Officer Changes on Jan 28 — 8-K · Feb 1, 2024
• BioSig Technologies Reports Material Modifications to Security Holder Rights — 8-K · Jan 31, 2024
• BioSig Confirms NASDAQ Listing for Common Stock — 8-K · Jan 30, 2024
• BioSig Sells $1M in Stock & Warrants to Institutional Investor — 8-K · Jan 12, 2024
• BioSig Technologies Confirms NASDAQ Listing & Corporate Info — 8-K · Jan 8, 2024